Inventor · disambiguated record

Don W. Cleveland

Also filed as: CLEVELAND DON · CLEVELAND DON W

17 granted patents·11 pending applications·82 citations·filing 1988–2025

93Inventor score

Technology areasC12N A61P G01N C07H A61K

Files withIONIS PHARMACEUTICALS INC13 RES INST NATIONWIDE CHILDRENS HOSPITAL4 UNIV CALIFORNIA4 BENNETT C FRANK1 HUNG GENE1

Top patents by PatentIndex Score

28 records

0195US10793861B2Products and methods for treatment of familial amyotrophic lateral sclerosisRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2018·Granted Oct 6, 2020·10 cites·15 claims
0295US9273315B2Modulation of huntingtin expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Mar 1, 2016·19 cites·14 claims
0393US10837016B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·2 cites·16 claims
0490US10619158B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Apr 14, 2020·2 cites·16 claims
0589US9963699B2Methods for modulating C9ORF72 expressionIONIS PHARMACEUTICALS INC·Filed 2013·Granted May 8, 2018·22 cites·28 claims
0689US9683236B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Jun 20, 2017·5 cites·16 claims
0788US9476051B2Antisense modulation of superoxide dismutase 1, soluble expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Oct 25, 2016·5 cites·20 claims
0887US11421231B2Modulation of Huntington expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Aug 23, 2022·1 cites·16 claims
0987US2024344071A1Products and Methods for Treatment of Amyotrophic Lateral SclerosisRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2024·Application pending·0 cites
1085US8906873B2Modulation of huntingtin expressionHUNG GENE·Filed 2010·Granted Dec 9, 2014·8 cites·8 claims
1184US10202603B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Feb 12, 2019·2 cites·16 claims
1282US12297431B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2022·Granted May 13, 2025·0 cites·14 claims
1377US11162096B2Methods for modulating expression of C9ORF72 antisense transcriptIONIS PHARMACEUTICALS INC·Filed 2017·Granted Nov 2, 2021·1 cites·27 claims
1475US2025154511A1Products and Methods for Treatment of Amyotrophic Lateral SclerosisRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2025·Application pending·0 cites
1572US2021108209A1Products and Methods for Treatment of Familial Amyotrophic Lateral SclerosisRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Application pending·0 cites
1671US2024316092A1Compounds and methods for increasing stmn2 expressionIONIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
1764US11833168B2Compounds and methods for increasing STMN2 expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Dec 5, 2023·0 cites·36 claims
1863US2021169916A1Methods for reducing c9orf72 expressionIONIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
1963US2016272976A1Products and methods for treatment of familial amyotrophic lateral sclerosisRES INST ATA NATIONWIDE CHILDREN'S HOSPITAL·Filed 2014·Application pending·0 cites
2061US2010081705A1Methods for slowing familial als disease progressionBENNETT C FRANK·Filed 2009·Application pending·0 cites
2158US2009076248A1Plus end-directed microtubule motor required for chromosome congressionUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
2253US2019142856A1Methods for reducing c9orf72 expressionIONIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
2352US7276331B2Plus end-directed microtubule motor required for chromosome congressionUNIV CALIFORNIA·Filed 2003·Granted Oct 2, 2007·0 cites·9 claims
2449US2009214524A1Methods and compositions for regulating cell cycle checkpointsLUDWIG INST CANCER RES·Filed 2003·Application pending·0 cites
2547US7009043B1Plus end-directed microtubule motor required for chromosome congressionUNIV CALIFORNIA·Filed 2000·Granted Mar 7, 2006·0 cites·13 claims
2645US2016237432A1Methods for modulating expression of c9orf72 antisense transcriptOINIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
2741US5196307ACloned human centromere autoantigenUNIV JOHNS HOPKINS·Filed 1988·Granted Mar 23, 1993·5 cites·10 claims
2830US6645748B1Plus end-directed microtubule motor required for chromosome congressionUNIV CALIFORNIA·Filed 1998·Granted Nov 11, 2003·0 cites·5 claims

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →